We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01728805
Recruitment Status : Active, not recruiting
First Posted : November 20, 2012
Last Update Posted : February 14, 2018
Information provided by (Responsible Party):
Kyowa Kirin Pharmaceutical Development, Inc. ( Kyowa Hakko Kirin Pharma, Inc. )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : March 2017
  Estimated Study Completion Date : December 2018
  Certification or Request for Extension to Delay Results Submission: February 9, 2018